While αSlamf6 treatment causes a significant loss of leukemic cells in the blood and spleen of TCL1-192-bearing SCID mice, as well as LMP2A/λMyc bearing Rag1−/− mice, both tumor cells remain in the peritoneal cavity of the recipient animals. This evidence concerns the gene MYCL and neoplasm.